Kaseya Unveils Its Major Event Line-Up for 2023
With five large customer-centric conferences and multiple one-day locals and symposiums, Kaseya offers a can’t-miss event for everyone in the...
With five large customer-centric conferences and multiple one-day locals and symposiums, Kaseya offers a can’t-miss event for everyone in the...
Frost & Sullivan recognizes NICE for its industry-leading solutions that deliver efficient and smart AI-powered digital-first experiences HOBOKEN, N.J.--(BUSINESS WIRE)--#NICE--NICE...
NIH RADx winner’s next gen Liberty16 Pro gets EUA AUCKLAND, New Zealand--(BUSINESS WIRE)--#COVIDCATCHER--Ubiquitome’s next generation real time PCR device system,...
Company envisions up to 1,000 jobs in Isahaya City as other sites near full capacity KYOTO, JAPAN--(BUSINESS WIRE)--Kyocera Corporation (President:...
Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis...
Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital Region that will host multiple...
MELBOURNE, Australia--(BUSINESS WIRE)--As rents continue to soar, Australian families are struggling more than ever before to find affordable housing. When...
DONGYING, China--(BUSINESS WIRE)--Dongying, a city in East China’s Shandong province, has been helping local enterprises expand in international markets as...
SAN FRANCISCO--(BUSINESS WIRE)--A third of global businesses predict the current inflationary environment to continue for more than two years, according...
HONG KONG SAR - Media Outreach - 19 December 2022 - Luxury beauty advisory SWISS REJU has been honored with...
HONG KONG SAR - Media OutReach - 19 December 2022 - A research team led by Hong Kong Baptist University...
HONG KONG SAR - Media OutReach - 19 December 2022 - LOFTER GROUP ("LOFTER" or "the Group"), a Hong Kong-based...
Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival benefit versus chemotherapy in...
First HER2 directed medicine to be approved for gastric cancer in the EU in more than a decade Based on...
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has decided to apply for the delisting of its shares of...